Ma Bing, Lau Leon H, Palcic Monica M, Hazes Bart, Taylor Diane E
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.
J Biol Chem. 2005 Nov 4;280(44):36848-56. doi: 10.1074/jbc.M504415200. Epub 2005 Sep 2.
Fucosyltransferases (FucT) from different Helicobacter pylori strains display distinct Type I (Galbeta1,3GlcNAc) or Type II (Galbeta1,4GlcNAc) substrate specificity. FucT from strain UA948 can transfer fucose to the OH-3 of Type II acceptors as well as to the OH-4 of Type I acceptors on the GlcNAc moiety, so it has both alpha1,3 and alpha1,4 activities. In contrast, FucT from strain NCTC11639 has exclusive alpha1,3 activity. Our domain swapping study (Ma, B., Wang, G., Palcic, M. M., Hazes, B., and Taylor, D. E. (2003) J. Biol. Chem. 278, 21893-21900) demonstrated that exchange of the hypervariable loops, (347)DNPFIFC(353) in 11639FucT and (345)CNDAHYSALH(354) in UA948FucT, were sufficient to either confer or abolish alpha1,4 activity. Here we performed alanine scanning site-directed mutagenesis to identify which amino acids within (345)CNDAHYSALH(354) of UA948FucT confer Type I substrate specificity. The Tyr(350) --> Ala mutation dramatically reduced alpha1,4 activity without lowering alpha1,3 activity. None of the other alanine substitutions selectively eliminated alpha1,4 activity. To elucidate how Tyr(350) determines alpha1,4 specificity, mutants Tyr(350) --> Phe, Tyr(350) --> Trp, and Tyr(350) --> Gly were constructed in UA948FucT. These mutations did not decrease alpha1,3 activity but reduced the alpha1,4 activity to 66.9, 55.6, and 3.1% [corrected] of wild type level, respectively. Apparently the aromatic nature, but not the hydroxyl group of Tyr(350), is essential for alpha1,4 activity. Our data demonstrate that a single amino acid (Tyr(350)) in the C-terminal hypervariable region of UA948FucT determines Type I acceptor specificity. Notably, a single aromatic residue (Trp) has also been implicated in controlling Type I acceptor preference for human FucT III, but it is located in an N-terminal hypervariable stem domain.
不同幽门螺杆菌菌株的岩藻糖基转移酶(FucT)表现出不同的I型(Galβ1,3GlcNAc)或II型(Galβ1,4GlcNAc)底物特异性。UA948菌株的FucT既能将岩藻糖转移到II型受体的OH-3位,也能转移到GlcNAc部分I型受体的OH-4位,所以它同时具有α1,3和α1,4活性。相比之下,NCTC11639菌株的FucT只具有α1,3活性。我们的结构域交换研究(Ma, B., Wang, G., Palcic, M. M., Hazes, B., and Taylor, D. E. (2003) J. Biol. Chem. 278, 21893 - 21900)表明,交换11639FucT中高变环(347)DNPFIFC(353)和UA948FucT中高变环(345)CNDAHYSALH(354),足以赋予或消除α1,4活性。在此,我们进行了丙氨酸扫描定点诱变,以确定UA948FucT的(345)CNDAHYSALH(354)中的哪些氨基酸赋予I型底物特异性。Tyr(350)→Ala突变显著降低了α1,4活性,而不降低α1,3活性。其他丙氨酸取代均未选择性消除α1,4活性。为了阐明Tyr(350)如何决定α1,4特异性,在UA948FucT中构建了Tyr(350)→Phe、Tyr(350)→Trp和Tyr(350)→Gly突变体。这些突变并未降低α1,3活性,但分别将α1,4活性降低至野生型水平的66.9%、55.6%和3.1%[校正后]。显然,Tyr(350)的芳香族性质而非羟基对于α1,4活性至关重要。我们的数据表明,UA948FucT C末端高变区的单个氨基酸(Tyr(350))决定I型受体特异性。值得注意的是,单个芳香族残基(Trp)也与控制人FucT III对I型受体的偏好有关,但它位于N末端高变茎结构域。